SCHEMBL9333237

SCHEMBL9333237

CN1CCCC(OC(=O)NCCO[N+](=O)[O-])C1

nearest known ligand 0.47

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.47
HTT P42858 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
CYP2D6 P10635 2/20 0.39
POLB P06746 1/20 0.39
EPHX1 P07099 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
ATM Q13315 1/20 0.37
ALDH1A1 P00352 1/20 0.36
CYP3A4 P08684 1/20 0.36
NTMT1 Q9BV86 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9330841 0.93 SMN1; SMN2 (0.48) SMN1; SMN2HTTL3MBTL1CYP2D6POLB
SCHEMBL9333430 0.85 CHRM3 (0.38) SMN1; SMN2EPHX1MEN1KMT2AALDH1A1
SCHEMBL9330747 0.81 SMN1; SMN2 (0.43) SMN1; SMN2HTTL3MBTL1CYP2D6POLB
SCHEMBL9333182 0.80 SMN1; SMN2 (0.55) SMN1; SMN2HTTL3MBTL1CYP2D6POLB
SCHEMBL9329947 0.79 MEN1 (0.35) EPHX1MEN1KMT2AALDH1A1
SCHEMBL9329952 0.79 SMN1; SMN2 (0.45) SMN1; SMN2HTTL3MBTL1CYP2D6POLB
SCHEMBL9330460 0.78 GAA (0.40) EPHX1MEN1KMT2AALDH1A1
SCHEMBL9330164 0.76 CHRM3 (0.46) EPHX1
SCHEMBL9333382 0.75 MEN1 (0.36) CYP2D6EPHX1MEN1KMT2AALDH1A1
Fumaric Acid SCHEMBL9346169 0.74 ITGB3 (0.42) CYP2D6ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0366004-B1 Cyclic azaaliphatic compounds with a nitroxy group, process for their preparation and pharmaceutical compositions thereof BOEHRINGER MANNHEIM GMBH (DE) 1994-03-30 EP disclosed
EP-0366004-A1 Cyclic azaaliphatic compounds with a nitroxy group, process for their preparation and pharmaceutical compositions thereof Roche Diagnostics GmbH (DE) 1990-05-02 EP disclosed